CD68 and neoplasm: Sections from 10 patients per tumor type of head and neck squamous cell carcinoma (HNSC), glioblastoma (GBM), melanoma (SKCM), non-small-cell lung carcinoma (NSCLC), high-grade serous ovarian carcinoma (HGSC), pancreatic ductal adenocarcinoma (PDAC) and stomach adenocarcinoma (STAD) were stained for hematoxylin and eosin, Masson’s Trichrome, anti-LAIR-1, NC410 and the immune cell markers, CD45, CD3, CD68 and CD163 (Figure 7B,, Figure 7—figure supplement 1).